CoChat
Sign Up
Cited by 100

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Analysis of cancer genomes reveals basic features of human aging and its role in cancer development

Podolskiy, Dmitriy I., Lobanov, Alexei V., Kryukov, Gregory V., Gladyshev, Vadim N.·2016·Nature Communications
DOI 10.1038/ncomms12157PMC PMC4990632
Open this paper in CoChat — free account

Abstract

Somatic mutations have long been implicated in aging and disease, but their impact on fitness and function is difficult to assess. Here by analysing human cancer genomes we identify mutational patterns associated with aging. Our analyses suggest that age-associated mutation load and burden double approximately every 8 years, similar to the all-cause mortality doubling time. This analysis further reveals variance in the rate of aging among different human tissues, for example, slightly accelerated aging of the reproductive system. Age-adjusted mutation load and burden correlate with the corresponding cancer incidence and precede it on average by 15 years, pointing to pre-clinical cancer development times. Behaviour of mutation load also exhibits gender differences and late-life reversals, explaining some gender-specific and late-life patterns in cancer incidence rates. Overall, this study characterizes some features of human aging and offers a mechanism for age being a risk factor for the onset of cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms12157

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 11 references

Research works printed but not linked: 41

  1. Sanders, S. J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012). · DOI · Paper page
  2. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011). · DOI · Paper page
  3. de Magalhães, J. P. How ageing processes influence cancer. Nat. Rev. Cancer 13, 357–365 (2013). · DOI · Paper page
  4. Lynch, M. Rate, molecular spectrum, and consequences of human mutation. Proc. Natl Acad. Sci. USA 107, 961–968 (2010). · DOI · Paper page
  5. Vijg, J. & Suh, Y. Genome instability and aging. Annu. Rev. Physiol. 75, 645–668 (2013). · DOI
  6. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013). · DOI · Paper page
  7. Tomasetti, C., Vogelstein, B. & Parmigiani, G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumour initiation. Proc. Natl Acad. Sci. USA 110, 1999–2004 (2013). · DOI
  8. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013). · DOI · Paper page
  9. Weinstein, J. N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113–1120 (2013). · DOI · Paper page
  10. Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 47, 1402–1407 (2015). · DOI
  11. Milholland, B., Auton, A., Suh, Y. & Vijg, J. Age-related somatic mutations in the cancer genome. Oncotarget 6, 24627–24635 (2015). · DOI
  12. Harding, C., Pompei, F., Lee, E. E. & Wilson, R. Cancer suppression at old age. Cancer Res. 68, 4465–4478 (2008). · DOI
  13. Harding, C., Pompei, F. & Wilson, R. Peak and decline in cancer incidence, mortality, and prevalence at old ages. Cancer 118, 1371–1386 (2012). · DOI
  14. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246–259 (2013). · DOI
  15. Francioli, L. C. et al. Genome-wide patterns and properties of de novo mutations in humans. Nat. Genet. 47, 822–826 (2015). · DOI
  16. Brown, P. O. & Palmer, C. The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med. 6, e1000114 (2009). · DOI
  17. Jones, S. et al. Comparative lesion sequencing provides insights into tumour evolution. Proc. Natl Acad. Sci. USA 105, 4283–4288 (2008). · DOI
  18. Klein, C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302–312 (2009). · DOI
  19. van Oortmarssen, G. J. & Habbema, J. D. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br. J. Cancer 64, 559–565 (1991). · DOI
  20. Peer, P. G. M., Van Dijck, J. A. A. M., Verbeek, A. L. M., Hendriks, J. H. C. L. & Holland, R. Age-dependent growth rate of primary breast cancer. Cancer 71, 3547–3551 (1993). · DOI
  21. Bialecki, E. S. & Di Bisceglie, A. M. Diagnosis of hepatocellular carcinoma. HPB (Oxford) 7, 26–34 (2005). · DOI
  22. Friberg, S. & Mattson, S. On the growth rates of human malignant tumours: implications for medical decision making. J. Surg. Oncol. 65, 284–297 (1997). · DOI
  23. Furukawa, H., Iwata, R. & Moriyama, N. Growth rate of pancreatic adenocarcinoma: initial clinical experience. Pancreas 22, 366–369 (2001). · DOI
  24. Haruma, K. et al. Evaluation of tumour growth rate in patients with early gastric carcinoma of the elevated type. Gastrointest. Radiol. 16, 289–292 (1991). · DOI
  25. Ozono, S. Tumour doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn. J. Clin. Oncol. 34, 82–85 (2004). · DOI
  26. Schmid, H.-P., McNeal, J. E. & Stamey, T. A. Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71, 2031–2040 (1993). · DOI
  27. Wang, J. C. et al. Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features. Br. J. Radiol. 73, 930–937 (2000). · DOI
  28. Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256–259 (2014). · DOI · Paper page
  29. Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225–233 (2014). · DOI
  30. Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751–759 (2015). · DOI
  31. Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353–357 (2015). · DOI
  32. Roberts, S. A. & Gordenin, D. A. Hypermutation in human cancer genomes: footprints and mechanisms. Nat. Rev. Cancer 14, 786–800 (2014). · DOI
  33. Hoeijmakers, J. H. J. DNA damage, aging, and cancer. New Engl. J. Med. 361, 1475–1485 (2009). · DOI · Paper page
  34. Schelter, B., Winterhalder, M. & Timmer, J. Handbook of Time Series Analysis: Recent Therorectical Developments and Applications (eds John Wiley & Sons (2006). · DOI
  35. Armitage, P. & Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8, 1–12 (1954). · DOI · Paper page
  36. Gladyshev, V. N. Aging: progressive decline in fitness due to the rising deleteriome adjusted by genetic, environmental, and stochastic processes. Aging Cell doi:10.1111/acel.12480 (2016). · DOI
  37. Cook, M. B. et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol. Biomarkers Prev. 18, 1174–1182 (2009). · DOI
  38. Cook, M. B., McGlynn, K. A., Devesa, S. S., Freedman, N. D. & Anderson, W. F. Sex disparities in cancer mortality and survival. Cancer Epidemiol. Biomarkers Prev 20, 1629–1637 (2011). · DOI
  39. Gladyshev, V. N. The origin of aging: imperfectness-driven non-random damage defines the aging process and control of lifespan. Trends Genet. 29, 506–512 (2013). · DOI
  40. Vaupel, J. W. Biodemography of human ageing. Nature 464, 536–542 (2010). · DOI · Paper page
  41. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010). · DOI · Paper page

Cited by

Sorted by citations

See all 100

Metadata

Authors
Podolskiy, D. I., Lobanov, A. V., Kryukov, G. V., & Gladyshev, V. N.
Venue
Nature Communications
Publisher
Springer Science and Business Media LLC
Published
2016-08-12
Volume
7
Issue
1
ISSN
2041-1723
DOI
10.1038/ncomms12157
PMC
PMC4990632
Cited by
100
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review